Polpharma appoints new head of Russian subsidiary
This article was originally published in Scrip
Polpharma, part of Hungary's Gedeon Richterand one of Poland's largest pharmaceutical manufacturers, has appointed Anastasia Antonenkova director of its Russian subsidiary, Polskie Lekarstva (Polish medicines), replacing Marina Veldanova. Ms Antonenkova's most recent position was financial director of Acrihin, a Russian pharmaceutical manufacturer acquired by Polpharma in 2007.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.